Cold Chain 2.0: Building a Resilient Temperature Controlled Network for Biologics and Gene Therapies
Cold chain failures don’t just cost money — they destroy product, delay treatment, and erode trust. Biologics and cell/gene therapies demand a level of temperature control that legacy cold chain systems were never designed to handle. The next generation of cold chain — Cold Chain 2.0 — integrates real‑time monitoring, redundancy, predictive analytics, and digital […]